
We are pleased to announce that Astraveus has successfully raised €16.5 Million in Seed financing to accelerate the development of our groundbreaking automated, microfluidic Cell and Gene Therapy manufacturing platform, #Lakhesys. Read more here: bit.ly/AVSseedPR





